Compare Abeona Therapeutics Inc (ABEO) vs GameStop Corp. (GME) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs GameStop Corp. — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while GameStop Corp. trades at $21.9 (market cap $9.96B). The key difference: GameStop Corp. is far larger — about 26.7× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, GameStop Corp. nearer its low. Which is the better fit depends on your goals.
| ABEO | GME | |
|---|---|---|
Market Cap | $373.32M | $9.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.23 | $27.69 |
52-Week Low | $4.17 | $19.94 |
Enterprise Value | $228.22M | $5.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
GME trades at $22.2, down 2.72% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported a net income margin of 20.45% for 2025, with recent quarterly earnings beating expectations. Key developments include shareholder approval for increased share issuance and CEO Ryan Cohen's focus on a potential eBay acquisition, alongside a withdrawn $35 billion pay package to prioritize the takeover bid.
The outlook is mixed, with strong profitability and bullish technicals offset by a cautious analyst consensus and strategic risks from the eBay pursuit. Investment opportunities lie in continued earnings growth and strategic initiatives, while risks include integration challenges, competitive pressures in physical media, and reliance on CEO-driven strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →
